Barry E Greene is a director of Karyopharm Therapeutics Inc.
Person profile
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Sage Therapeutics, Inc.
15 Feb 24
4
Sage Therapeutics, Inc.
8 Aug 23
4
Karyopharm Therapeutics Inc.
25 May 23
4
Sage Therapeutics, Inc.
15 Feb 23
4
Sage Therapeutics, Inc.
15 Nov 22
4
Karyopharm Therapeutics Inc.
15 Aug 22
4
Karyopharm Therapeutics Inc.
20 May 22
4
Sage Therapeutics, Inc.
15 Feb 22
4
Sage Therapeutics, Inc.
9 Aug 21
4
Sage Therapeutics, Inc.
17 Jun 21
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
13 Feb 24 | SAGE Sage Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 23.02 | 168,000 | 3.87 mm | 168,000 |
4 Aug 23 | SAGE Sage Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 85.82 | 195,000 | 16.73 mm | 195,000 |
24 May 23 | KPTI Karyopharm Therapeutics | Nonstatutory Stock Option Common Stock | Grant | Acquire A | No | No | 2.5 | 34,000 | 85.00 k | 34,000 |
13 Feb 23 | SAGE Sage Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 45.28 | 66,500 | 3.01 mm | 66,500 |
10 Nov 22 | SAGE Sage Therapeutics | Common Stock | Buy | Acquire P | No | No | 34.4843 | 14,500 | 500.02 k | 46,940 |